99 related articles for article (PubMed ID: 9666512)
1. Acetylation and phosphorylation of the carboxy-terminal domain of p53: regulative significance.
Chiarugi V; Cinelli M; Magnelli L
Oncol Res; 1998; 10(2):55-7. PubMed ID: 9666512
[TBL] [Abstract][Full Text] [Related]
2. Signaling to p53: breaking the posttranslational modification code.
Appella E; Anderson CW
Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the specific DNA binding activity of Xenopus laevis p53: evidence for conserved regulation through the carboxy-terminus of the protein.
Bessard AC; Garay E; Lacronique V; Legros Y; Demarquay C; Houque A; Portefaix JM; Granier C; Soussi T
Oncogene; 1998 Feb; 16(7):883-90. PubMed ID: 9484779
[TBL] [Abstract][Full Text] [Related]
4. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
[TBL] [Abstract][Full Text] [Related]
5. Modulation of binding of DNA to the C-terminal domain of p53 by acetylation.
Friedler A; Veprintsev DB; Freund SM; von Glos KI; Fersht AR
Structure; 2005 Apr; 13(4):629-36. PubMed ID: 15837201
[TBL] [Abstract][Full Text] [Related]
6. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
[TBL] [Abstract][Full Text] [Related]
7. Structure of the human p53 core domain in the absence of DNA.
Wang Y; Rosengarth A; Luecke H
Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):276-81. PubMed ID: 17327663
[TBL] [Abstract][Full Text] [Related]
8. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
9. The DNA binding regulatory domain of p53: see the C.
Wolkowicz R; Rotter V
Pathol Biol (Paris); 1997 Dec; 45(10):785-96. PubMed ID: 9769942
[TBL] [Abstract][Full Text] [Related]
10. How phosphorylation regulates the activity of p53.
Steegenga WT; van der Eb AJ; Jochemsen AG
J Mol Biol; 1996 Oct; 263(2):103-13. PubMed ID: 8913292
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1.
Wesierska-Gadek J; Wojciechowski J; Schmid G
J Cell Biochem; 2003 Aug; 89(6):1260-84. PubMed ID: 12898523
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53.
van Dieck J; Teufel DP; Jaulent AM; Fernandez-Fernandez MR; Rutherford TJ; Wyslouch-Cieszynska A; Fersht AR
J Mol Biol; 2009 Dec; 394(5):922-30. PubMed ID: 19819244
[TBL] [Abstract][Full Text] [Related]
13. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53.
Kim E; Albrechtsen N; Deppert W
Oncogene; 1997 Aug; 15(7):857-69. PubMed ID: 9266973
[TBL] [Abstract][Full Text] [Related]
14. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential.
Mundt M; Hupp T; Fritsche M; Merkle C; Hansen S; Lane D; Groner B
Oncogene; 1997 Jul; 15(2):237-44. PubMed ID: 9244359
[TBL] [Abstract][Full Text] [Related]
15. Fmoc-based chemical synthesis and selective binding to supercoiled DNA of the p53 C-terminal segment and its phosphorylated and acetylated derivatives.
Teruya K; Murphy AC; Burlin T; Appella E; Mazur SJ
J Pept Sci; 2004 Aug; 10(8):479-93. PubMed ID: 15347136
[TBL] [Abstract][Full Text] [Related]
16. Promoter-specific p53-dependent histone acetylation following DNA damage.
Kaeser MD; Iggo RD
Oncogene; 2004 May; 23(22):4007-13. PubMed ID: 15007388
[TBL] [Abstract][Full Text] [Related]
17. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
18. DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site.
Blaydes JP; Hupp TR
Oncogene; 1998 Aug; 17(8):1045-52. PubMed ID: 9747884
[TBL] [Abstract][Full Text] [Related]
19. Recognition of cisplatin-damaged DNA by p53 protein: critical role of the p53 C-terminal domain.
Pivonková H; Brázdová M; Kaspárková J; Brabec V; Fojta M
Biochem Biophys Res Commun; 2006 Jan; 339(2):477-84. PubMed ID: 16300733
[TBL] [Abstract][Full Text] [Related]
20. Advantage of a baculovirus expression system for protein-protein interaction studies. Involvement of posttranslational phosphorylation in the interaction between wt p53 protein and poly(ADP-ribose) polymerase-1.
Schmid G; Wojciechowski J; Wesierska-Gadek J
Acta Biochim Pol; 2005; 52(3):713-9. PubMed ID: 16082409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]